SCHEMBL13644748

SCHEMBL13644748

CB(O)N1CC[C@@H](N)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12124646 1.00 — —
SCHEMBL13885624 1.00 — —
SCHEMBL13117961 0.87 DPP4 (0.30) —
SCHEMBL773506 0.86 GNAI3 (0.32) —
SCHEMBL12129040 0.77 CHRNA7 (0.31) —
SCHEMBL12129011 0.77 CHRNA7 (0.31) —
SCHEMBL25746459 0.77 CHRNA7 (0.31) —
SCHEMBL19154844 0.74 — —
SCHEMBL25746464 0.72 DPP4 (0.33) —
SCHEMBL13389359 0.70 CA1 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090264498-A1 Cathepsin C Inhibitors GLAXO GROUP LIMITED (GB) 2009-10-22 — — US disclosed
US-20090264499-A1 Cathepsin C Inhibitors GLAXO GROUP LIMITED (GB) 2009-10-22 — — US disclosed
US-7514442-B2 Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors SCHERING CORPORATION (US) 2009-04-07 — — US disclosed
US-7205308-B2 Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors SCHERING CORPORATION (US) 2007-04-17 — — US disclosed
Send feedback